FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brad Rovin

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Neeraj Singh; Arvinder Bhinder; Jonathan McNeely; Samir Parikh; Brad H Rovin; Ganesh Shidham
Kidney complications of hematopoietic stem cell transplantation.
Nicholas A Young; Daniel J Birmingham; Alexandra K Friedman; Lee A Hebert; Benjamin Kaffenberger; Murugesan V S Rajaram; Brad H Rovin; Larry S Schlesinger; Lai-Chu Wu; Wael N Jarjour
Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.
Chi Chiu Mok; Daniel J Birmingham; Lee A Hebert; Ling Yin Ho; Brad H Rovin
High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brad Rovin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Neeraj Singh; Arvinder Bhinder; Jonathan McNeely; Samir Parikh; Brad H Rovin; Ganesh Shidham
Kidney complications of hematopoietic stem cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2013;61(5):809-21.
2013: Nicholas A Young; Daniel J Birmingham; Alexandra K Friedman; Lee A Hebert; Benjamin Kaffenberger; Murugesan V S Rajaram; Brad H Rovin; Larry S Schlesinger; Lai-Chu Wu; Wael N Jarjour
Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.
Molecular immunology 2013;54(1):23-31.
2013: Chi Chiu Mok; Daniel J Birmingham; Lee A Hebert; Ling Yin Ho; Brad H Rovin
High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus.
Arthritis care & research 2013;65(3):441-7.
2013: Xiaolan Zhang; Brad H Rovin
Beyond anemia: hepcidin, monocytes and inflammation.
Biological chemistry 2013;394(2):231-8.
2013: Rachel Roth; Brad H Rovin; Grigory Rozenblit; Anjali Satoskar; Jon Von Visger; Jamison Foster; Lee Hebert; Dayanand Makey; Gyongyi Nadasdy; Tibor Nadasdy; Samir Parikh; Sergey V Brodsky
When size matters: diagnostic value of kidney biopsy according to the gauge of the biopsy needle.
American journal of nephrology 2013;37(3):249-54.
2013: Brad H Rovin; Paul Brunetta; Tak Mao Chan; Ellen M Ginzler; Lee A Hebert; Lai Seong Hooi; Romeo Maciuca; Chi Chiu Mok; Samir V Parikh; Neil Solomons
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Clinical journal of the American Society of Nephrology : CJASN 2013;8(1):147-53.
2013: Brad H Rovin
Targeting B-cells in lupus nephritis: should cautious optimism remain?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28(1):7-9.
2012: John P Shapiro; Cenny Taslim; Sabyasachi Biswas; Shili Lin; Anand S Merchant; Brad H Rovin; Sashwati Roy; Anjali Satoskar; Chandan K Sen; Michael A Freitas
A quantitative proteomic workflow for characterization of frozen clinical biopsies: laser capture microdissection coupled with label-free mass spectrometry.
Journal of proteomics 2012;77():433-40.
2012: Brad H Rovin
Lupus nephritis: guidelines for lupus nephritis--more recommendations than data?
Nature reviews. Nephrology 2012;8(11):620-1.
2012: Hermine I Brunner; Michael R Bennett; Adnan N Kiani; RINA MINA; Joshua Pendl; Michelle Petri; Brad H Rovin; Michiko Suzuki; David Witte; Jun Ying; Prasad Devarajan
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.
Arthritis and rheumatism 2012;64(8):2687-97.
2012: Daniel J Birmingham; Lee A Hebert; Haikady N Nagaraja; W T Noonan; Brad H Rovin; H Song; C Yung Yu
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans.
Lupus 2012;21(8):855-64.
2012: Anjali A Satoskar; John P Shapiro; Huijuan Song; Daniel J Birmingham; Cherri N Bott; Sergey V Brodsky; Michael A Freitas; Lee A Hebert; Gyongyi Nadasdy; Tibor Nadasdy; Brad H Rovin
Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(5):709-21.
2012: Brad H Rovin; Jorge Sanchez-Guerrero; David Zhang; Gerald Appel; Paul Brunetta; Fernando C Fervenza; Richard Furie; Jay P Garg; Kevin Latinis; R John Looney; Romeo Maciuca
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Arthritis and rheumatism 2012;64(4):1215-26.
2012: Chi Chiu Mok; Daniel J Birmingham; Lee A Hebert; Hoi Wah Leung; Huijuan Song; Brad H Rovin
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.
Rheumatology (Oxford, England) 2012;51(4):644-52.
2012: Xiaolan Zhang; Huijuan Song; Swapna Kamadana; Alison McKinley; Tibor Nadasdy; Haikady N Nagaraja; Jason Prosek; Brad H Rovin
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies.
Kidney international 2012;81(4):401-6.
2012: Sergey V Brodsky; Brad H Rovin; Lee A Hebert
Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(2):475-7.
2012: Sheldon Hirsch; Udayan Bhatt; Jackie Hirsch; Brad H Rovin
Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success.
American journal of nephrology 2012;36(5):430-7.
2011: A A Satoskar; Brad H Rovin; C Bott; S V Brodsky; Lee A Hebert; Gyongyi Nadasdy; Tibor Nadasdy
Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis.
Lupus 2011;20(13):1396-403.
2011: Kyle Ware; Haifeng Wu; Udayan Bhatt; Polina Brodsky; Lee A Hebert; Gyongyi Nadasdy; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Jon Von Visger; Sergey V Brodsky
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.
Journal of the American Society of Nephrology : JASN 2011;22(10):1856-62.
2011: Stacy Ardoin; Daniel J Birmingham; Paul L Hebert; Brad H Rovin; Chack-Yung Yu; Lee A Hebert
An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.
Arthritis and rheumatism 2011;63(7):2031-7.
2011: Sergey V Brodsky; Udayan Y Bhatt; Gyongyi Nadasdy; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Haifeng M Wu; Lee A Hebert
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.
Kidney international 2011;80(2):181-9.
2011: J Winoto; H Song; C Hines; Haikady N Nagaraja; Brad H Rovin
Cytochrome P450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy.
Clinical nephrology 2011;75(5):451-7.
2011: Michael L Merchant; Adam E Gaweda; Andrew J Dailey; Daniel W Wilkey; Xiaolan Zhang; Brad H Rovin; Klein Jon; Michael E Brier
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.
Kidney international 2011;79(5):546-54.
2011: Chadwick E Barnes; Raul A Hernandez; Leena S Hiremath; Tibor Nadasdy; Brad H Rovin; Anjali A Satoskar; Rose L Shim; Christopher Valentine; William A Wilmer; Lee A Hebert
Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.
Nephron. Clinical practice 2011;119(2):c145-53.
2011: Lee A Hebert; Brad H Rovin
Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?
Nephron. Clinical practice 2011;117(1):c8-14.
2010: Xiaolan Zhang; Brad H Rovin
Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines.
Biochimica et biophysica acta 2010;1800(12):1262-7.
2010: Andrew S Bomback; Huijuan Song; Vivette D D'Agati; Scott D Cohen; Alison Neal; Gerald B Appel; Brad H Rovin
A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(10):3442-6.
2010: Daniel J Birmingham; F Irshaid; Haikady N Nagaraja; X Zou; B P Tsao; H Wu; C Yung Yu; Lee A Hebert; Brad H Rovin
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.
Lupus 2010;19(11):1272-80.
2010: William Blum; Mitch A Phelps; Rebecca B Klisovic; Darlene M Rozewski; Wenjun Ni; Katie A Albanese; Brad H Rovin; Cheryl Kefauver; Steven M Devine; David M Lucas; Amy Johnson; Larry J Schaaf; John C Byrd; Guido Marcucci; Michael R Grever
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias.
Haematologica 2010;95(7):1098-105.
2010: Srividya Viswanathan; Brad H Rovin; Ganesh B Shidham; Subha V Raman; Mitchell Weinberg; Allenby Patricia; James N George; Haifeng M Wu; Spero R Cataland
Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura.
British journal of haematology 2010;149(4):623-5.
2010: Lee A Hebert; Brad H Rovin
Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
Annals of internal medicine 2010;152(1):64; author reply 65.
2010: Paula Budu-Grajdeanu; Richard C Schugart; Avner Friedman; Daniel J Birmingham; Brad H Rovin
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.
Theoretical biology & medical modelling 2010;7():14.
2010: Sergey V Brodsky; Michael Collins; Edward Park; Brad H Rovin; Anjali A Satoskar; Gyongyi Nadasdy; Haifeng Wu; Udayan Bhatt; Tibor Nadasdy; Lee A Hebert
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease.
Nephron. Clinical practice 2010;115(2):c142-6.
2009: Derek M Fine; Martina Ziegenbein; Michelle Petri; Ernest C Han; Alison M McKinley; Jerry W Chellini; Haikady N Nagaraja; Kathryn Carson; Brad H Rovin
A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis.
Kidney international 2009;76(12):1284-8.
2009: Alison McKinley; Edward Park; Dan Spetie; Kevin V Hackshaw; Smitha Nagaraja; Lee A Hebert; Brad H Rovin
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(11):1754-60.
2009: Brad H Rovin; Xiaolan Zhang
Biomarkers for lupus nephritis: the quest continues.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(11):1858-65.
2009: Brad H Rovin; Alison M McKinley; Daniel J Birmingham
Can we personalize treatment for kidney diseases?
Clinical journal of the American Society of Nephrology : CJASN 2009;4(10):1670-6.
2009: Brad H Rovin
Glomerular disease: Lupus nephritis treatment: are we beyond cyclophosphamide?
Nature reviews. Nephrology 2009;5(9):492-4.
2009: Michael L Merchant; Bruce A Perkins; Grzegorz M Boratyn; Linda H Ficociello; Daniel W Wilkey; Michelle T Barati; Clinton C Bertram; Grier P Page; Brad H Rovin; James H Warram; Andrzej S Krolewski; Klein Jon
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.
Journal of the American Society of Nephrology : JASN 2009;20(9):2065-74.
2009: Huijuan Song; James Chan; Brad H Rovin
Induction of chemokine expression by adiponectin in vitro is isoform dependent.
Translational research : the journal of laboratory and clinical medicine 2009;154(1):18-26.
2009: Noa Schwartz; Tamar Rubinstein; Linda C Burkly; Christopher E Collins; Irene Blanco; Lihe Su; Bernard Hojaili; Meggan Mackay; Cynthia Aranow; William Stohl; Brad H Rovin; Jennifer S Michaelson; Chaim Putterman
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
Arthritis research & therapy 2009;11(5):R143.
2009: Lee A Hebert; Daniel J Birmingham; Ganesh Shidham; Brad H Rovin; Haikady N Nagaraja; Chack-Yung Yu
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients.
Nephron. Clinical practice 2009;113(3):c177-82.
2008: Michael Collins; Sankar D Navaneethan; Miriam Chung; James Sloand; Bruce Goldman; Gerald Appel; Brad H Rovin
Rituximab treatment of fibrillary glomerulonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(6):1158-62.
2008: Haifeng Wu; Daniel J Birmingham; Brad H Rovin; Kevin V Hackshaw; Nabil Haddad; Douglas Haden; Chack-Yung Yu; Lee A Hebert
D-dimer level and the risk for thrombosis in systemic lupus erythematosus.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(6):1628-36.
2008: Xiaolan Zhang; Ming Jin; Haifeng Wu; Tibor Nadasdy; Gyongyi Nadasdy; Nathan Harris; Kari B Green-Church; Haikady N Nagaraja; Daniel J Birmingham; C Yung Yu; Lee A Hebert; Brad H Rovin
Biomarkers of lupus nephritis determined by serial urine proteomics.
Kidney international 2008;74(6):799-807.
2008: Ruo-Qi Hu; Hashim Mehter; Tibor Nadasdy; Anjali Satoskar; Dan N Spetie; Brad H Rovin; Lee Hebert
Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review.
Rheumatology international 2008;28(11):1161-4.
2008: Daniel J Birmingham; Brad H Rovin; Ganesh Shidham; Michael Bissell; Haikady N Nagaraja; Lee A Hebert
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(4):1028-33.
2008: Uday S Nori; Anil K Agarwal; Brad H Rovin
Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
The New England journal of medicine 2008;358(12):1302-3; author reply 1303-4.
2008: Paula Budu-Grajdeanu; Richard C Schugart; Avner Friedman; Christopher Valentine; Anil Agarwal; Brad H Rovin
A mathematical model of venous neointimal hyperplasia formation.
Theoretical biology & medical modelling 2008;5():2.
2008: Mark J Siedner; Allan C Gelber; Brad H Rovin; Alison M McKinley; Lisa Christopher-Stine; Brad C Astor; Michelle Petri; Derek M Fine
Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis.
The Journal of rheumatology 2008;35(1):84-90.
2008: Brad H Rovin
The chemokine network in systemic lupus erythematous nephritis.
Frontiers in bioscience : a journal and virtual library 2008;13():904-22.
2007: Brad H Rovin; Daniel Roncone; Alison McKinley; Tibor Nadasdy; Stephen M Korbet; Melvin M Schwartz
APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.
The New England journal of medicine 2007;357(24):2522-4.
2007: Brad H Rovin; Lee A Hebert
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker.
Kidney international 2007;72(12):1423-6.
2007: Daniel J Birmingham; Brad H Rovin; Ganesh Shidham; Haikady N Nagaraja; X Zou; Michael Bissell; C Yung Yu; Lee A Hebert
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares.
Kidney international 2007;72(7):865-70.
2007: Yee Ling Wu; Stephanie L Savelli; Yan Yang; Bi Zhou; Brad H Rovin; Daniel J Birmingham; Haikady N Nagaraja; Lee A Hebert; C Yung Yu
Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):3012-25.
2007: Daniel J Birmingham; Fawzi Irshaid; Katie Gavit; Haikady N Nagaraja; C Yung Yu; Brad H Rovin; Lee A Hebert
A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
Molecular immunology 2007;44(14):3510-6.
2007: Yan Yang; Erwin K Chung; Yee Ling Wu; Stephanie L Savelli; Haikady N Nagaraja; Bi Zhou; Maddie Hebert; Karla N Jones; Yaoling Shu; Kathryn Kitzmiller; Carol A Blanchong; Kim McBride; Gloria C Higgins; Robert M Rennebohm; Robert R Rice; Kevin V Hackshaw; Robert A S Roubey; Jennifer M Grossman; Betty P Tsao; Daniel J Birmingham; Brad H Rovin; Lee A Hebert; C Yung Yu
Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.
American journal of human genetics 2007;80(6):1037-54.
2007: Daniel Roncone; Anjali A Satoskar; Tibor Nadasdy; J Paul Monk; Brad H Rovin
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma.
Nature clinical practice. Nephrology 2007;3(5):287-93.
2007: Lizhong Wang; Shili Lin; Kottil W. Rammohan; Zhenqiu Liu; Jin-qing Liu; Runhua Liu; Nikki Guinther; Judy Lima; Qunmin Zhou; Tony Wang; Xincheng Zheng; Daniel J Birmingham; Brad H Rovin; Lee A Hebert; Yeeling Wu; D Joanne Lynn; Glenn Cooke; C Yung Yu; Pan Zheng; Yang Liu
A dinucleotide deletion in CD24 confers protection against autoimmune diseases.
PLoS genetics 2007;3(4):e49.
2007: Hui Wu; Susan A Boackle; Punchong Hanvivadhanakul; Daniela Ulgiati; Jennifer M Grossman; Youngho Lee; Nan Shen; Lawrence J Abraham; Timothy R Mercer; Elly Park; Lee A Hebert; Brad H Rovin; Daniel J Birmingham; Deh-Ming Chang; Chung Jen Chen; Deborah McCurdy; Humeira M Badsha; B Y H Thong; Hiok H Chng; Frank C Arnett; Daniel J Wallace; C Yung Yu; Bevra H Hahn; Rita M Cantor; Betty P Tsao
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):3961-6.
2007: Lee A Hebert; Brad H Rovin; Christopher J Hebert
The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
Nature clinical practice. Nephrology 2007;3(2):60-1.
2007: John C Byrd; Thomas S Lin; James T Dalton; Di Wu; Mitch A Phelps; Beth Fischer; Mollie Moran; Kristie A Blum; Brad H Rovin; Michelle Brooker-McEldowney; Sarah Broering; Larry J Schaaf; Amy J Johnson; David M Lucas; Nyla A Heerema; Gerard Lozanski; Donn C Young; Jose-Ramon Suarez; A Dimitrios Colevas; Michael R Grever
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.
Blood 2007;109(2):399-404.
2007: Brad H Rovin; Daniel J Birmingham; Haikady N Nagaraja; C Yung Yu; Lee A Hebert
Biomarker discovery in human SLE nephritis.
Bulletin of the NYU hospital for joint diseases 2007;65(3):187-93.
2006: Noa Schwartz; Lihe Su; Linda C Burkly; Meggan Mackay; Cynthia Aranow; Maria Kollaros; Jennifer S Michaelson; Brad H Rovin; Chaim Putterman
Urinary TWEAK and the activity of lupus nephritis.
Journal of autoimmunity 2006;27(4):242-50.
2006: Daniel J Birmingham; Haikady N Nagaraja; Brad H Rovin; Lacramioara Spetie; Yanxing Zhao; Xiaobai Li; Kevin V Hackshaw; C Yung Yu; William B Malarkey; Lee A Hebert
Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele.
Arthritis and rheumatism 2006;54(10):3291-9.
2006: Brad H Rovin; Huijuan Song
Chemokine induction by the adipocyte-derived cytokine adiponectin.
Clinical immunology (Orlando, Fla.) 2006;120(1):99-105.
2006: Xi-Lin Chen; Geraldine Dodd; Suzanne Thomas; Xiaolan Zhang; Martin A Wasserman; Brad H Rovin; Charles Kunsch
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression.
American journal of physiology. Heart and circulatory physiology 2006;290(5):H1862-70.
2006: Daniel J Birmingham; Katie Gavit; S M McCarty; C Yung Yu; Brad H Rovin; Haikady N Nagaraja; Lee A Hebert
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.
Clinical and experimental immunology 2006;143(2):274-80.
2006: Yee-Ling Wu; Gloria C Higgins; Robert M Rennebohm; Erwin K Chung; Yan Yang; Bi Zhou; Haikady N Nagaraja; Daniel J Birmingham; Brad H Rovin; Lee A Hebert; C Yung Yu
Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.
Advances in experimental medicine and biology 2006;586():227-47.
2006: Yubing Xie; Xihai Kang; William Ackerman; Martha A Belury; C Koster; Brad H Rovin; M B Landon; Douglas A Kniss
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins.
Diabetes, obesity & metabolism 2006;8(1):83-93.
2005: Xiaolan Zhang; Xilin Chen; Huijuan Song; Hui-Zi Chen; Brad H Rovin
Activation of the Nrf2/antioxidant response pathway increases IL-8 expression.
European journal of immunology 2005;35(11):3258-67.
2005: Brad H Rovin; Huijuan Song; Lee A Hebert; Tibor Nadasdy; Gyongyi Nadasdy; Daniel J Birmingham; Chack Yung Yu; Haikady N Nagaraja
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.
Kidney international 2005;68(4):1825-33.
2005: William Ackerman; Xiaolan L Zhang; Brad H Rovin; Douglas A Kniss
Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.
Biology of reproduction 2005;73(3):527-35.
2005: Hui Wu; Rita M Cantor; Deborah S Cunninghame Graham; Cecilia M Lingren; Lisa Farwell; Philip L De Jager; Nunzio Bottini; Jennifer M Grossman; Daniel J Wallace; Bevra H Hahn; Heikki Julkunen; Lee A Hebert; Brad H Rovin; Daniel J Birmingham; John D Rioux; C Yung Yu; Juha Kere; Timothy J Vyse; Betty P Tsao
Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease.
Arthritis and rheumatism 2005;52(8):2396-402.
2005: Brad H Rovin; Yuxiao Tang; Junfeng Sun; Haikady N Nagaraja; Kevin V Hackshaw; Linda Gray; Robert Rice; Daniel J Birmingham; C Yung Yu; Dan N Spetie; Amy Aziz; Lee A Hebert
Clinical significance of fever in the systemic lupus erythematosus patient receiving steroid therapy.
Kidney international 2005;68(2):747-59.
2005: Lee A Hebert; Brad H Rovin; Anil Agarwal; Dan N Spetie
Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(4):788-9; author replyy 789-90.
2005: Enrique Gonzalez; Hemant Kulkharni ; Hector Bolivar; Andrea MAngano; Racquel Sanchez; Gabriel Catano; Robert J B Nibbs; Barry I Freedman; Marlon P Quinones; Michael Bamshad; Krishna K Murthy; Brad H Rovin; William Bradley; Robert Clark; Stephanie A Anderson; Robert J O'Connell; Brian Agan; Seema Ahuja; Rosa Bologna; Luisa Sen; Matthew J Dolan; Sunil Ahuja
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
Science (New York, N.Y.) 2005;307(5714):1434-40.
2005: Brad H Rovin; Huijuan Song; Daniel J Birmingham; Lee A Hebert; C Yung Yu; Haikady N Nagaraja
Urine chemokines as biomarkers of human systemic lupus erythematosus activity.
Journal of the American Society of Nephrology : JASN 2005;16(2):467-73.
2004: Dan N Spetie; Yuxiao Tang; Brad H Rovin; Tibor Nadasdy; Gyongyi Nadasdy; Todd E Pesavento; Lee A Hebert
Mycophenolate therapy of SLE membranous nephropathy.
Kidney international 2004;66(6):2411-5.
2004: William Ackerman; Brad H Rovin; Douglas A Kniss
Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells.
Biology of reproduction 2004;71(6):2079-86.
2004: Visith Thongboonkerd; Michelle T Barati; Kenneth R McLeish; Charaf Benarafa; Eileen Remold-O'Donnell; Shirong Zheng; Brad H Rovin; William M Pierce; Paul N Epstein; Klein Jon
Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis.
Journal of the American Society of Nephrology : JASN 2004;15(3):650-62.
2004: Xiaolan Zhang; Ling Lu; Cynthia Dixon; William A Wilmer; Huijuan Song; Xilin Chen; Brad H Rovin
Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells.
Kidney international 2004;65(3):798-810.
2004: Yan Yang; Erwin K Chung; Bi Zhou; Karl Lhotta; Lee A Hebert; Daniel J Birmingham; Brad H Rovin; C Yung Yu
The intricate role of complement component C4 in human systemic lupus erythematosus.
Current directions in autoimmunity 2004;7():98-132.
2003: Xiaolan Zhang; Hui-Zi Chen; Brad H Rovin
Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin.
BioTechniques 2003;35(6):1144-6, 1148.
2003: William A Wilmer; Brad H Rovin; Christopher J Hebert; Sunil V Rao; Karen Kumor; Lee A Hebert
Management of glomerular proteinuria: a commentary.
Journal of the American Society of Nephrology : JASN 2003;14(12):3217-32.
2003: Mustafa Atalay; Gayle M Gordillo; Sashwati Roy; Brad H Rovin; DEBASIS BAGCHI; Manashi Bagchi; Chandan K Sen
Anti-angiogenic property of edible berry in a model of hemangioma.
FEBS letters 2003;544(1-3):252-7.
2003: Vicki R Kelley; Brad H Rovin
Chemokines: therapeutic targets for autoimmune and inflammatory renal disease.
Springer seminars in immunopathology 2003;24(4):411-21.
2002: William A Wilmer; Cynthia L Dixon; Christopher J Hebert; Ling Lu; Brad H Rovin
PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells.
Antioxidants & redox signaling 2002;4(6):877-84.
2002: Enrique Gonzalez; Brad H Rovin; Luisa Sen; Glen Cooke; Rahul Dhanda; Srinivas Mummidi; Hemant Kulkharni ; Michael Bamshad; Vanessa Telles; Stephanie A Anderson; Elizabeth A Walter; Kevin T Stephan; Michael Deucher; Andrea MAngano; Rosa Bologna; Seema Ahuja; Matthew J Dolan; Sunil Ahuja
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(21):13795-800.
2002: Julie-Randoph Randolph-Habecker; Brian M Rahill; Beverly Torok-Storb; Jeffrey Vieira; Pappachan Kolattukudy; Brad H Rovin; Daniel D Sedmak
The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production.
Cytokine 2002;19(1):37-46.
2002: Brad H Rovin; Ling Lu; Xiaolan Zhang
A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis.
Kidney international 2002;62(1):261-5.
2002: Brad H Rovin; William A Wilmer; Ling Lu; Andrea I Doseff; Cynthia Dixon; Mark Kotur; Todd Hilbelink
15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death.
Kidney international 2002;61(4):1293-302.
2001: Brad H Rovin; Ling Lu; A Cosio
Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells.
Journal of the American Society of Nephrology : JASN 2001;12(8):1659-67.
2001: Lee A Hebert; William A Wilmer; Michael E Falkenhain; S E Ladson-Wofford; N Stanley Nahman; Brad H Rovin
Renoprotection: one or many therapies?
Kidney international 2001;59(4):1211-26.
2001: Brad H Rovin; L Lu; Clay B Marsh
Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.
Journal of leukocyte biology 2001;69(3):435-9.
2001: William A Wilmer; Cynthia Dixon; Ling Lu; T Hilbelink; Brad H Rovin
A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma.
Biochemical and biophysical research communications 2001;281(1):57-62.
2001: Daniel J Birmingham; Brad H Rovin; C Yung Yu; Lee A Hebert
Of mice and men: the relevance of the mouse to the study of human SLE.
Immunologic research 2001;24(2):211-24.
2001: Douglas A Kniss; Brad H Rovin; RH Fertel; Peter D Zimmerman
Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells.
Placenta 2001;22(1):80-9.
1999: Brad H Rovin
Chemokines as therapeutic targets in renal inflammation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(4):761-4; discussion 765-7.
1999: Brad H Rovin; Ling Lu; R Saxena
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.
Biochemical and biophysical research communications 1999;259(2):344-8.
1999: Brad H Rovin; William A Wilmer; MM Danne; JA Dickerson; Cynthia L Dixon; Ling Lu
The mitogen-activated protein kinase p38 is necesssary for interleukin 1beta-induced monocyte chemoattractant protein 1 expression by human mesangial cells.
Cytokine 1999;11(2):118-26.
1998: Brad H Rovin; L T Phan
Chemotactic factors and renal inflammation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(6):1065-84.
1998: Clay B Marsh; MP Lowe; Brad H Rovin; JM Parker; Z Liao; Daren L Knoell; Mark D Wewers
Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(8):3942-8.
1997: William A Wilmer; LC Tan; JA Dickerson; MM Danne; Brad H Rovin
Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation.
The Journal of biological chemistry 1997;272(16):10877-81.
1997: Brad H Rovin; JA Dickerson; LC Tan; J Fassler
Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status.
Cytokine 1997;9(3):178-86.
1997: Clay B Marsh; Mark D Wewers; LC Tan; Brad H Rovin
Fc(gamma) receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte Fc(gamma)RIII.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1078-84.
1996: Brad H Rovin; N Doe; L C Tan
Monocyte chemoattractant protein-1 levels in patients with glomerular disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;27(5):640-6.
1995: Brad H Rovin; J A Dickerson; L C Tan; C A Hebert
Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells.
Kidney international 1995;48(4):1263-71.
1995: Brad H Rovin; L C Tan; K L Leonhart; N Stanley Nahman
Cyclic adenosine monophosphate and protein kinase C modulate fibronectin production in cultured human mesangial cells.
The Journal of laboratory and clinical medicine 1995;126(2):216-23.
1994: Brad H Rovin; M Rumancik; L Tan; J Dickerson
Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.
Laboratory investigation; a journal of technical methods and pathology 1994;71(4):536-42.
1994: Brad H Rovin; L C Tan
Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells.
Kidney international 1994;46(4):1059-68.
1994: Fernando G Cosio; T Shibata; Brad H Rovin; Daniel J Birmingham
Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
Kidney international 1994;46(4):986-92.
1993: Brad H Rovin; P Bou-Khalil; Daniel D Sedmak
Pulmonary-renal syndrome in a patient with fibrillary glomerulonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(5):713-6.
1993: Brad H Rovin; L C Tan
LDL stimulates mesangial fibronectin production and chemoattractant expression.
Kidney international 1993;43(1):218-25.
1992: Brad H Rovin; T Yoshiumura; L Tan
Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(7):2148-53.